Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
469 Leser
Artikel bewerten:
(2)

BGO Software - https://www.bgosoftware.com/: New Open-Source GMP Platform Now Available to Pharma Manufacturers

Scalable, User-Friendly Data Management Solution Offers Innovation, Integration, and Transparency for Pharma Operations.

SOFIA, BG / ACCESS Newswire / January 20, 2025 / A leading global pharmaceutical company has launched the open-source Data Computation Platform (DCP), a GMP- compliant solution designed for pharmaceutical manufacturers. The platform offersreal-time monitoring, process optimization, and batch analysis, improving efficiency and compliance.

" The launch of DCP marks a major step forward for the pharmaceutical industry. The platform is highly useful and inspiring, empowering organizations to achieve GMP compliance, enhance operational efficiency, and future-proof their processes. As a main development and implementation partner of the platform across all the pharmaceutical company's manufacturing sites, we are ready to help companies to integrate this scalable, open-source GMP platform to unlock its full potential.", said Harry Birimirski, GMP Solutions Architect at BGO Software.

Designed with a microservice-based architecture, the platform offers scalability, flexibility, and seamless integration into existing workflows.

How:

The platform uses advanced statistical techniques, including Principal Component Analysis (PCA), Partial Least Squares (PLS), and Statistical Process Control (SPC). These methods provide actionable insights, enhance decision-making, and maintain consistent quality across operations.

Key Benefits of the DCP Platform:

  • Smart Data Analytics: Transforms complex pharmaceutical data into insights using advanced algorithms.

  • Real-Time Quality Control: Enables precise process monitoring and early deviation detection across manufacturing operations.

  • Easy System Integration and Scalable Architecture: Connects with any system, while modular microservices enable feature updates without disruption.

  • Protect sensitive data with full encryption: Access control while compliant with GMP standards through built-in validation tools.

  • Transparent and Intuitive Design: Open-source transparency ensures adaptability, no vendor lock-in, and an user-friendly interface designed for pharmaceutical workflows.

BGO Software: Integration Made Simple

BGO Software - a key development partner in the field of digital health - simplifies platform integration for predictive modeling, machine learning, and process monitoring, tailoring solutions to meet GMP compliance and operational needs, whether supporting in-house teams or full implementation.

BGO's integration services include:

  • Custom Implementation: Tailored deployments that adapt to existing systems, processes, and workflows.

  • Fast Turnaround: Seamless platform implementation, often within 10 days for standard setups.

  • End-to-End Support: From planning and verification to training and ongoing assistance, BGO ensures minimal disruption during deployment.

How to Try it:

If your team is interested in enhancing performance with the new digital health companies' tool, you can request a system demo of the open-source GMP solution through BGO Software. After a brief overview, BGO experts provide full access, allowing hands-on exploration of its capabilities and operational benefits.

Request a Demo Today: Contact BGO Software to discover how DCP can transform your pharmaceutical manufacturing processes.

Contact:
BGO Software
Email: info@bgosoftware.com
Phone: +44-208-191-7757
Website: https://www.bgosoftware.com/

About BGO Software:

BGO Software is a trusted partner in delivering innovative, GMP-compliant solutions for the pharmaceutical industry, achieving global success and collaborating with top 20 pharmaceutical and clinical research industry leaders. Specializing in multi-site operations, pharma-specific data management, and seamless system integrations, BGO combines technical expertise with deep industry knowledge to support organizations in achieving operational excellence.

Contact Information

BGO Software
Custom Healthcare Software Development Company
info@bgosoftware.com
+44-208-191-7757

.

SOURCE: BGO Software - https://www.bgosoftware.com/



© 2025 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.